Robust T cell activation kills tumors regardless of T cell specificity
RNA-seq (gene expression) · mouse · 39 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 39 samples: 39 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE324375_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1434514 and SRA study SRP682386. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 39 sample titles: 39 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9574578 Tumor, baseline or relevant peptide treated (12h), channel 1, RNA
- GSM9574579 Tumor, baseline or relevant peptide treated (12h), channel 2, RNA
- GSM9574580 Tumor, relevant (48h) or irrelevant peptide treated (12h), channel 1, RNA
- GSM9574581 Tumor, relevant (48h) or irrelevant peptide treated (12h), channel 2, RNA
- GSM9574582 Tumor, irrelevant (48h) or relevant peptide treated (12h), channel 1, RNA
- GSM9574583 Tumor, irrelevant (48h) or relevant peptide treated (12h), channel 2, RNA
- GSM9574584 Tumor, innate agonist treated, channel 1, RNA
- GSM9574585 Tumor, innate agonist treated, channel 2, RNA
- GSM9574586 Tumor, baseline or relevant peptide treated (12h), channel 1, ADT
- GSM9574587 Tumor, baseline or relevant peptide treated (12h), channel 2, ADT
- GSM9574588 Tumor, relevant (48h) or irrelevant peptide treated (12h), channel 1, ADT
- GSM9574589 Tumor, relevant (48h) or irrelevant peptide treated (12h), channel 2, ADT
- GSM9574590 Tumor, irrelevant (48h) or relevant peptide treated (12h), channel 1, ADT
- GSM9574591 Tumor, irrelevant (48h) or relevant peptide treated (12h), channel 2, ADT
- GSM9574592 Tumor, innate agonist treated, channel 1, ADT
- GSM9574593 Tumor, innate agonist treated, channel 2, ADT
- GSM9574594 Tumor, baseline or relevant peptide treated (12h), channel 1, HTO
- GSM9574595 Tumor, baseline or relevant peptide treated (12h), channel 2, HTO
- GSM9574596 Tumor, relevant (48h) or irrelevant peptide treated (12h), channel 1, HTO
- GSM9574597 Tumor, relevant (48h) or irrelevant peptide treated (12h), channel 2, HTO
- GSM9574598 Tumor, irrelevant (48h) or relevant peptide treated (12h), channel 1, HTO
- GSM9574599 Tumor, irrelevant (48h) or relevant peptide treated (12h), channel 2, HTO
- GSM9574600 Tumor, innate agonist treated, channel 1, HTO
- GSM9574601 Tumor, innate agonist treated, channel 2, HTO
- GSM9574602 Tumor, relevant peptide treated (12h), RNA
- GSM9574603 Tumor, relevant peptide treated (48h), RNA
- GSM9574604 Tumor, irrelevant peptide treated (12h), RNA
- GSM9574605 Tumor, irrelevant peptide treated (48h), RNA
- GSM9574606 Tumor, innate agonist treated (12h), RNA
- GSM9574607 Tumor, relevant peptide treated (12h), ADT
- GSM9574608 Tumor, relevant peptide treated (48h), ADT
- GSM9574609 Tumor, irrelevant peptide treated (12h), ADT
- GSM9574610 Tumor, irrelevant peptide treated (48h), ADT
- GSM9574611 Tumor, innate agonist treated (12h), ADT
- GSM9574612 Tumor, relevant peptide treated (12h), HTO
- GSM9574613 Tumor, relevant peptide treated (48h), HTO
- GSM9574614 Tumor, irrelevant peptide treated (12h), HTO
- GSM9574615 Tumor, irrelevant peptide treated (48h), HTO
- GSM9574616 Tumor, innate agonist treated (12h), HTO
- GSE270717 The m6A demethylase FTO controls activation-induced cell death in effector CD8+ T cells by modulating Fas expression 10 samples shares activation
- GSE314859 The degradation of maternal RNA-binding protein 4E-T regulates translational activation to ensure maternal-to-zygotic transition in mouse embryos 67 samples shares activation
- GSE327880 Neuronal activation triggers rapid biphasic FMRP-mediated translational control linking synaptic and nuclear regulation 51 samples shares activation
- GSE276667 A multivalent mRNA vaccine elicits robust immune responses and confers protection in a murine model of monkeypox virus infection 18 samples shares robust
- GSE255212 Transcriptomic Signatures of WNT-Driven Pathways and Granulosa Cell-Oocyte Interaction during Primordial Follicle Activation 762 samples shares activation
- GSE276632 Reciprocal genetic screens identify epigenetics factors controlling epidermal cell activation. 262 samples shares activation
- GSE297515 Piezo1-dependent activation of stromal cells ignites muscle inflammation in exercise and injury and is associated with inflammaging 90 samples shares activation
- GSE201228 CD4+ T cell activation in absence of WNK1 72 samples shares activation
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.